Resources

AFA Healthcare Pioneers Report – Showcasing Best Practice In AF 2018

by

The AF Association – Healthcare Pioneers Report 2018 includes 38 articles describing ways of finding patients with undiagnosed AF using, for example smartphones or simple pulse checks, methods to ensure that adequate assessment is undertaken to define underlying causes and potential complications, treatment techniques involving antiarrhythmic drugs to suppress the development of AF, anticoagulant drug therapy to prevent AF-related stroke, left atrial ablation (a technique to try and prevent further attacks of AF), and more.

More Additional Reading

Independent evaluation of the AHSN Network mobile ECG roll-out programme

The national roll out of mobile ECG devices by Academic Health Science Networks (AHSNs) was born out of a system-wide procurement initiative to promote the uptake of a digital technology (mobile ECG). This was a novel approach to facilitate innovation adoption which prompted the AHSN Network to commission an independent evaluation of the roll out, at AHSN level, to understand its effectiveness, and in particular what can be learned about: the environments in which the devices are most effective, what characterises an effective implementation package, the impact on the market place, patients (through AF detection) and providers; and the health economic aspects of this type of programme.

Clinical guide for the management of anticoagulant services during the coronavirus pandemic

Anticoagulant services may not seem to be in the frontline with coronavirus but we do have a key role in continuing to keep patients on anticoagulants as safe as possible; this must be planned. In response to pressures on the NHS, the way we deliver anticoagulants may need to change. We should seek the best local solutions to continue the safe management of patients on anticoagulation while protecting resources for the response to coronavirus

Public Health England CVD Ambitions

A new coalition led by Public Health England (PHE) and NHS England has announced the first ever national ambitions to improve the detection and treatment of atrial fibrillation, high blood pressure and high cholesterol (A-B-C) – the major causes of cardiovascular disease (CVD).
This site is intended for Healthcare Professionals only

If you are not a healthcare professional, please Click Here